Click here to visit our new markets resource hub for the latest on the evolving trade landscape
Answer a few quick questions about your business and we'll direct you to incentives, programs, and services you may be eligible for.
When it comes to innovation in rapid diagnostics, few companies make waves like MedMira. Headquartered in Halifax, Nova Scotia, this biotechnology leader is transforming the global conversation around rapid testing - developing the world’s fastest test platform, Rapid Vertical Flow Technology (RVF), and securing approvals from top-tier regulators like Health Canada and the U.S. FDA.
But what’s equally remarkable is where this innovation is happening - right here in Nova Scotia.
A Global Business, Deep Local Roots
MedMira has built an impressive track record in developing rapid tests for HIV, Hepatitis B and C, Syphilis, COVID-19, and other major health concerns. Their pioneering technology enables fast, accurate, and multiple results from a single sample. And they’re not stopping there. The company’s patented MiROQ system is poised to disrupt the industry once again, providing fast and affordable quantitative diagnostics within minutes.
So why does a company with global clients, including military organizations like the U.S. Army and Canadian forces, continue to call Nova Scotia home?
It Starts with People
“MedMira has its certified facility here in Nova Scotia with employees who are deeply committed to the company and to the province,” says Hermes Chan, CEO of MedMira. “Knowledge and experience are invaluable assets, and we’re rooted in our people.”
Nova Scotia’s educated workforce, especially in medicine, biology, and chemistry, is a key driver for MedMira’s ongoing success. The province’s strong post-secondary institutions provide a steady pipeline of talent that turns ideas into real-world solutions.
A Life Sciences Ecosystem that Works
MedMira’s team credits Nova Scotia’s collaborative research environment for accelerating their product development. Close partnerships with local universities enable scientific breakthroughs and the validation of cutting-edge technologies. These partnerships help MedMira stay agile and ahead of the curve in a highly competitive field.
Stability, Access, and Opportunity
Nova Scotia’s secure and stable environment also offers strategic advantages. “In these turbulent times, Nova Scotia is calm and secure,” explains Chan. “And from a logistics standpoint, our access to major global markets in the U.S. and Europe is ideal.”
That blend of lifestyle, accessibility, and innovation capacity is a compelling mix for any business looking to grow.
A Call for Local Collaboration
Looking ahead, MedMira is eager to work with health organizations and government partners to improve health outcomes across the province. They’re preparing to launch Health Canada approved rapid tests in Nova Scotia aimed at increasing early detection of sexually transmitted infections - offering scalable, reliable tools that can save lives and reduce pressure on the healthcare system.
“Rapid testing increases awareness, improves public health, and saves time and cost for healthcare providers,” says Chan. “We’re here to make Nova Scotia healthier.”
Putting Nova Scotia on the Global Map
MedMira is one of only a few companies with multiple Health Canada approvals for rapid tests and one of just five with an FDA-approved HIV rapid test. Their success story is elevating Nova Scotia’s credibility on the global stage.
As they prepare for the launch of their game-changing MiROQ system, MedMira’s spotlight continues to grow - and with it, so does interest in Nova Scotia as a premier location for life sciences innovation.
Looking to grow your company in a place where ideas, talent, and opportunity intersect? Nova Scotia, Canada may just be the perfect fit. Connect with Vanessa Pierson to expand your search horizons to Nova Scotia, Canada.
